Opening Day 1 (II) - Introduction to Randomized Controlled Trials_ Ananta Bangdiwala
Day 1 (II) - Introduction to Randomized Controlled Trials_ Ananta Bangdiwala
- Length
- 25 min
- Level
- Undergraduate
- Recorded
- Christian Medical College Vellore2025
Chapter 1 of 4: Phases of clinical trials
Compares randomized trial phases, master protocols, and infectious disease study designs.
Clinical trial design distinguishes between phases, disease types, and operational frameworks to evaluate medical interventions. The discussion contrasts acute infectious disease trials with chronic disease studies by examining primary endpoints, timelines, and intervention strategies. Pragmatic trials and pilot studies address real-world constraints and establish feasibility before launching large-scale research projects. Master protocols such as basket, umbrella, and platform trials improve operational efficiency by sharing resources and infrastructure across multiple evaluations. Practical examples from cryptococcal meningitis research illustrate how these trial architectures function in resource-limited clinical environments.
Clinical trial design distinguishes between phases, disease types, and operational frameworks to evaluate medical interventions. The discussion contrasts acute infectious disease trials with chronic disease studies by examining primary endpoints, timelines, and intervention strategies. Pragmatic trials and pilot studies address real-world constraints and establish feasibility before launching large-scale research projects. Master protocols such as basket, umbrella, and platform trials improve operational efficiency by sharing resources and infrastructure across multiple evaluations. Practical examples from cryptococcal meningitis research illustrate how these trial architectures function in resource-limited clinical environments.
ENACT trial
AMPLYX trial
ASTRO trial
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Thabane L, et al. BMC Med Res Methodol. 2010 Jan 6;10:1.
Lu CC, et al. Ther Innov Regul Sci. 2021 Nov;55(6):1145-1154

This lecture
Lecture 17 of 18 of CLINICAL TRIALS COURSE 2025.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Therapeutic Innovation & Regulatory Science